Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swapnil Potdar

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
NPJ Precision Oncology|July 24, 2021
Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemiaBrian S White, Suleiman A Khan, Mike J Mason, et al.
Oncotarget|February 11, 2017
Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitorsPaavo O Pietarinen, Christopher A Eide, Pilar Ayuda-Durán, et al.
Cancer Discovery|November 18, 2021
Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid LeukemiaDisha Malani, Ashwini Kumar, Oscar Brück, et al.
Cell Reports Methods|September 6, 2023
Image-based and machine learning-guided multiplexed serology test for SARS-CoV-2Vilja Pietiäinen, Minttu Polso, Ede Migh, et al.
Nature Reviews. Drug Discovery|March 19, 2025
Computational drug repurposing: approaches, evaluation of in silico resources and case studiesZiaurrehman Tanoli, Adrià Fernández-Torras, Umut Onur Özcan, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
NPJ Precision Oncology|July 24, 2021
Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemiaBrian S White, Suleiman A Khan, Mike J Mason, et al.
Oncotarget|February 11, 2017
Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitorsPaavo O Pietarinen, Christopher A Eide, Pilar Ayuda-Durán, et al.
Cancer Discovery|November 18, 2021
Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid LeukemiaDisha Malani, Ashwini Kumar, Oscar Brück, et al.
Cell Reports Methods|September 6, 2023
Image-based and machine learning-guided multiplexed serology test for SARS-CoV-2Vilja Pietiäinen, Minttu Polso, Ede Migh, et al.
Nature Reviews. Drug Discovery|March 19, 2025
Computational drug repurposing: approaches, evaluation of in silico resources and case studiesZiaurrehman Tanoli, Adrià Fernández-Torras, Umut Onur Özcan, et al.
Pageof 4